multiplemyelomahorizon.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot /
BingBot /
BaiduSpider /
YandexBot /
User-Agent: * Allow:
Meta Tags
Title Multiple Myeloma
Description EXPANDING THE HORIZON IN RELAPSED OR REFRACTORY MULTIPLE Learn about the need for additional treatment for advanced cases of relapsed/refractory multiple myeloma. See how BCMA and CD3 therapies can be new targets for
Keywords N/A
Server Information
WebSite multiplemyelomahorizon faviconmultiplemyelomahorizon.com
Host IP 54.192.99.52
Location United States
Related Websites
Site Rank
More to Explore
multiplemyelomahorizon.com Valuation
US$279,187
Last updated: 2023-05-19 17:25:09

multiplemyelomahorizon.com has Semrush global rank of 37,911,163. multiplemyelomahorizon.com has an estimated worth of US$ 279,187, based on its estimated Ads revenue. multiplemyelomahorizon.com receives approximately 32,214 unique visitors each day. Its web server is located in United States, with IP address 54.192.99.52. According to SiteAdvisor, multiplemyelomahorizon.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$279,187
Daily Ads Revenue US$258
Monthly Ads Revenue US$7,732
Yearly Ads Revenue US$92,776
Daily Unique Visitors 2,148
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
multiplemyelomahorizon.com. 1799 IN A IP: d17txsccua3df7.cloudfront.net.
d17txsccua3df7.cloudfront.net. 58 IN A IP: 54.192.99.52
d17txsccua3df7.cloudfront.net. 58 IN A IP: 54.192.99.53
d17txsccua3df7.cloudfront.net. 58 IN A IP: 54.192.99.120
d17txsccua3df7.cloudfront.net. 58 IN A IP: 54.192.99.115
multiplemyelomahorizon.com. 1798 IN AAAA IPV6: d17txsccua3df7.cloudfront.net.
multiplemyelomahorizon.com. 1798 IN NS NS Record: d17txsccua3df7.cloudfront.net.
d17txsccua3df7.cloudfront.net. 7199 IN NS NS Record: ns-968.awsdns-57.net.
d17txsccua3df7.cloudfront.net. 7199 IN NS NS Record: ns-385.awsdns-48.com.
d17txsccua3df7.cloudfront.net. 7199 IN NS NS Record: ns-1867.awsdns-41.co.uk.
d17txsccua3df7.cloudfront.net. 7199 IN NS NS Record: ns-1067.awsdns-05.org.
multiplemyelomahorizon.com. 1798 IN MX MX Record: d17txsccua3df7.cloudfront.net.
multiplemyelomahorizon.com. 1797 IN TXT TXT Record: d17txsccua3df7.cloudfront.net.
HtmlToTextCheckTime:2023-05-19 17:25:09
The Challenge The Target Share Sign Up Sign Up! EXPANDING THE HORIZON IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA Relapsed or refractory multiple myeloma is a complex disease, the treatment of which would benefit from further study and investigation. There remains a critical need for new approaches in later lines. 1 Treating advanced cases in relapsed or refractory multiple myeloma remains a significant challenge There remains a need for improved treatment options for patients with relapsed or refractory multiple myeloma, including those who have progressed following treatment with multiple classes of drugs. As multiple myeloma progresses, relapses become more aggressive with each line of therapy, and remissions become progressively shorter. 1-7 Triple class refractory disease occurs when patients relapse on or are refractory to one proteasome inhibitor, one immunomodulatory agent, and one anti-CD38 monoclonal antibody. 8-11 Proteasome Inhibitors Immunomodulatory Agents Anti-CD38
HTTP Headers
HTTP/1.1 301 Moved Permanently
Server: CloudFront
Date: Wed, 02 Nov 2022 08:49:48 GMT
Content-Type: text/html
Content-Length: 167
Connection: keep-alive
Location: https://multiplemyelomahorizon.com/
X-Cache: Redirect from cloudfront
Via: 1.1 350f2b5d7e6ee985da330b123098fd88.cloudfront.net (CloudFront)
X-Amz-Cf-Pop: ARN1-C1
X-Amz-Cf-Id: 641PMv-Nv00iU-CNke1sDLcb7pk4ksXOJFj-M9QQmS8N0GaQpY7-1g==
X-XSS-Protection: 1; mode=block
X-Frame-Options: SAMEORIGIN
Referrer-Policy: same-origin
Content-Security-Policy: default-src *; script-src * 'unsafe-eval' 'self' 'unsafe-inline' https:; style-src * 'unsafe-inline'; object-src 'self' *.youtube.com youtube.com; img-src * data:; frame-src *; font-src * data:; connect-src *; media-src * blob:; worker-src 'self' blob:;
X-Content-Type-Options: nosniff

HTTP/1.1 200 OK
Content-Type: text/html
Content-Length: 80722
Connection: keep-alive
Date: Wed, 02 Nov 2022 08:49:49 GMT
Cache-Control: max-age=3600
Last-Modified: Wed, 17 Aug 2022 15:39:14 GMT
ETag: "a177a5e01270182069b90b143aebde75"
Server: AmazonS3
X-Cache: Miss from cloudfront
Via: 1.1 8ea75fde43c768e7e1d041f8b7a07bd6.cloudfront.net (CloudFront)
X-Amz-Cf-Pop: ARN56-P1
X-Amz-Cf-Id: 99RwOo7LR9godPfT_pFVNLdMoQ0PX3nXwcX9AaIY4jyr6tQ1j9w1Dw==
X-XSS-Protection: 1; mode=block
X-Frame-Options: SAMEORIGIN
Referrer-Policy: same-origin
Content-Security-Policy: default-src *; script-src * 'unsafe-eval' 'self' 'unsafe-inline' https:; style-src * 'unsafe-inline'; object-src 'self' *.youtube.com youtube.com; img-src * data:; frame-src *; font-src * data:; connect-src *; media-src * blob:; worker-src 'self' blob:;
X-Content-Type-Options: nosniff
Strict-Transport-Security: max-age=63072000; includeSubDomains; preload
multiplemyelomahorizon.com Whois Information
Domain Name: MULTIPLEMYELOMAHORIZON.COM
Registry Domain ID: 2683188072_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.rrpproxy.net
Registrar URL: http://www.key-systems.net
Updated Date: 2022-03-21T14:19:27Z
Creation Date: 2022-03-21T14:19:22Z
Registry Expiry Date: 2023-03-21T14:19:22Z
Registrar: Key-Systems GmbH
Registrar IANA ID: 269
Registrar Abuse Contact Email: abuse@key-systems.net
Registrar Abuse Contact Phone: +49.68949396850
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: NS1.JNJ.COM
Name Server: NS3.JNJ.COM
Name Server: NS5.JNJ.COM
DNSSEC: unsigned
>>> Last update of whois database: 2022-11-02T08:52:45Z <<<